Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Study highlights cardio safety of Lilly GLP-1 dulaglutide
Study highlights cardio safety of Lilly GLP-1 dulaglutide
Study highlights cardio safety of Lilly GLP-1 dulaglutide
Submitted by
admin
on May 23, 2012 - 12:05pm
Source:
Pharma Times, UK
News Tags:
Eli Lilly
dulaglutide
diabetes
Headline:
Study highlights cardio safety of Lilly GLP-1 dulaglutide
Do Not Allow Advertisers to Use My Personal information
